| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5989581 | ORGANON USA ORGANON | Drug delivery system for two or more active substances |
Apr, 2018
(6 years ago) | |
Nuvaring is owned by Organon Usa Organon.
Nuvaring contains Ethinyl Estradiol; Etonogestrel.
Nuvaring has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Nuvaring are:
- US5989581
Nuvaring was authorised for market use on 03 October, 2001.
Nuvaring is available in ring;vaginal dosage forms.
The generics of Nuvaring are possible to be released after 08 April, 2018.
Drugs and Companies using ETHINYL ESTRADIOL; ETONOGESTREL ingredient
Market Authorisation Date: 03 October, 2001
Treatment: NA
Dosage: RING;VAGINAL
How can I launch a generic of NUVARING before it's drug patent expiration?
More Information on Dosage
NUVARING family patents
